Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Medtronic PLC (MDT : NYSE)

• Company Description    Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. Number of Employees: 95,000

• Price / Volume Information    Yesterday's Closing Price: $101.59 Daily Weekly Monthly 20 Day Moving Average: 14,662,195 shares Shares Outstanding: 1,279.14 (millions) Market Capitalization: $129,947.62 (millions) Beta: 0.56 52 Week High: $106.33 52 Week Low: $73.31 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.22% 13.36% 12 Week 10.32% 12.82% Year To Date 5.76% -3.74%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BUILDING TWO PARKMORE BUSINESS PARK WEST - GALWAY,L2 H91 IRL ph: 353-1438-1700 fax: 763-514-4879 investor.relations@medtronic.com http://www.medtronic.com

• General Corporate Information    Officers Geoffrey S. Martha - Chairman and Chief Executive Officer Thierry Pieton - Executive Vice President and Chief Financial Offic Denise L. Blomquist - Vice President and Chief Accounting Officer Michelle Quinn - Executive Vice President; General Counsel and Secr Craig Arnold - Director Peer Information Medtronic PLC (BJCT) Medtronic PLC (CADMQ) Medtronic PLC (APNO) Medtronic PLC (UPDC) Medtronic PLC (IMTIQ) Medtronic PLC (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G5960L103 SIC: 3845 Fiscal Year Fiscal Year End: April Last Reported Quarter: 07/01/26 Next Expected EPS Date: 11/24/26 Share - Related Items Shares Outstanding: 1,279.14 Most Recent Split Date: 9.00 (2.00:1) Beta: 0.56 Market Capitalization: $129,947.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.83% Current Fiscal Quarter EPS Consensus Estimate: $1.43 Indicated Annual Dividend: $2.88 Current Fiscal Year EPS Consensus Estimate: $5.98 Payout Ratio: 0.50 Number of Estimates in the Fiscal Year Consensus: 12.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 7.15% Last Dividend Paid: 09/25/2026 - $0.72 Next EPS Report Date: 11/24/26

• Fundamental Ratios P/E Current FY Estimate: 17.00 Trailing 12 Months: 17.76 PEG Ratio: 2.38 Price Ratios Price/Book: 2.56 Price/Cash Flow: 12.94 Price / Sales: 3.46 EPS Growth vs. Year Ago Period: 15.08% vs. Previous Quarter: -6.45% Sales Growth vs. Year Ago Period: 13.73% vs. Previous Quarter: -0.52% ROE 10/31/26 - - 07/31/26 - 14.78 04/30/26 - 14.51 ROA 10/31/26 - - 07/31/26 - 7.97 04/30/26 - 7.76 Current Ratio 10/31/26 - - 07/31/26 - 2.07 04/30/26 - 2.13 Quick Ratio 10/31/26 - - 07/31/26 - 1.54 04/30/26 - 1.62 Operating Margin 10/31/26 - - 07/31/26 - 19.59 04/30/26 - 19.58 Net Margin 10/31/26 - - 07/31/26 - 13.93 04/30/26 - 13.20 Pre-Tax Margin 10/31/26 - - 07/31/26 - 17.59 04/30/26 - 16.87 Book Value 10/31/26 - - 07/31/26 - 39.75 04/30/26 - 39.00 Inventory Turnover 10/31/26 - - 07/31/26 - 2.13 04/30/26 - 2.09 Debt-to-Equity 10/31/26 - - 07/31/26 - 0.50 04/30/26 - 0.52 Debt-to-Capital 10/31/26 - - 07/31/26 - 33.50 04/30/26 - 34.33

Powered by Zacks Investment Research ©